Members Can Post Anonymously On This Site
-
Similar Topics
-
By NASA
NASA White Sands Test Facility
Las Cruces, New Mexico
Soil Remediation at the 600 Area Off-Site Pile
Origins of the 600 Area Off-Site Pile
The NASA White Sands Test Facility (WSTF) is crucial for supporting space exploration and technology development. Located in New Mexico, it provides a controlled environment for testing and evaluating spacecraft, propulsion systems, and other aerospace technologies. The facility is instrumental in conducting critical tests such as engine firings, thermal and environmental testing, and materials research. Its role in ensuring the safety, reliability, and performance of spacecraft and systems makes it a key asset in NASA’s mission to explore space and advance scientific knowledge. Unfortunately, past practices associated with the execution of its mission adversely impacted soil and groundwater resources.
From June 1974 to December 1979, sludge and soil removed from a domestic and industrial wastewater lagoon was stockpiled on Bureau of Land Management land west of the NASA White Sands Test Facility (WSTF) facility boundary, less than a mile from the lagoon. When accumulation of material ceased, the sludge/soil debris pile lay dormant with no boundary identification. In 1993, during a Resource Conservation and Recovery Act field investigation the debris pile was identified and reported to the New Mexico Environment Department (NMED) and designated as Solid Waste Management Unit (SWMU) 16.
Investigation Summary
Initial investigations were completed at SWMU 16 in 2015 and 2018 to characterize the stockpiled sludge/soil and native soils beneath the stockpile to a depth of 30 feet. Analysis of soil sample data indicated the contaminants in the pile posed a risk to human health and the environment due to identified concentrations of nitrates, metals, volatile and semi-volatile organics, pesticides, polychlorinated biphenyls, and dioxins and furans. The NMED agreed to the removal and off-site disposal of New Mexico Special Waste in 2021.
Removal, Disposal, Confirmation Sampling
Excavation of the stockpile and the upper 6 inches of native soil was completed in January 2024. Excavation of native soils extended approximately 10 ft beyond the extent of the pile. A total of 1,072.7 tons of sludge and soil were disposed at the Corralitos Landfill. In February 2024, confirmatory soil samples were collected from 38 locations on a 30-foot grid established across SWMU 16, encompassing the location of the removed stockpile and all areas potentially affected by site operations. These samples were submitted for laboratory chemical analyses to determine if NASA had met is remedial objectives and eliminated the exposure risk to human health and the environment.
Risk Assessment
The results showed that NASA had succeeded. The site was restored. Results of soil sample analyses did not identify site contaminants remain at the site, and a risk assessment did not identify elevated risk to receptors or to groundwater beneath the site. NASA concluded that site contaminants have been removed, the risk to human health and the environment are below regulatory targets. NASA recommended a change in site status from “Requiring Corrective Action” to “Corrective Action Complete without Controls”. The report of results is currently under review by the NMED.
Visit nasa.gov/emd to learn more about NASA’s Environmental Management Division (EMD)!
View the full article
-
-
By NASA
6 min read
Preparations for Next Moonwalk Simulations Underway (and Underwater)
In-person participants L-R standing: Dave Francisco, Joanne Kaouk, Dr. Richard Moon, Dr. Tony Alleman, Dr. Sean Hardy, Sarah Childress, Kristin Coffey, Dr. Ed Powers, Dr. Doug Ebersole, Dr. Steven Laurie, Dr. Doug Ebert; L-R seated: Dr. Alejandro Garbino, Dr. Robert Sanders, Dr. Kristi Ray, Dr. Mike Gernhardt, Dr. Joseph Dervay, Dr. Matt Makowski). Not pictured: Dr. Caroline Fife In June 2024, the NASA Office of the Chief Health and Medical Officer (OCHMO) Standards Team hosted an independent assessment working group to review the status and progress of research and clinical activities intended to mitigate the risk of decompression sickness (DCS) related to patent foramen ovale (PFO) during spaceflight and associated ground testing and human subject studies.
Decompression sickness (DCS) is a condition which results from dissolved gases (primarily nitrogen) forming bubbles in the bloodstream and tissues. It is usually experienced in conditions where there are rapid decreases in ambient pressure, such as in scuba divers, high-altitude aviation, or other pressurized environments. The evolved gas bubbles have various physiological effects and can obstruct the blood vessels, trigger inflammation, and damage tissue, resulting in symptoms of DCS. NASA presently classifies DCS into two categories: Type I DCS, which is less severe, typically leads to musculoskeletal symptoms including pain in the joints or muscles, or skin rash. Type II DCS is more severe and commonly results in neurological, inner ear, and cardiopulmonary symptoms. The risk of DCS in spaceflight presents during extravehicular activities (EVAs) in which astronauts perform mission tasks outside the spaceflight vehicle while wearing a pressurized suit at a lower pressure than the cabin pressure. DCS mitigation protocols based on strategies to reduce systemic nitrogen load are implemented through the combination of habitat environmental parameters, EVA suit pressure, and breathing gas procedures (prebreathe protocols) to achieve safe and effective mission operations. The pathophysiology of DCS has still not been fully elucidated since cases occur despite the absence of detected gas bubbles but includes right to left shunting of venous gas emboli (VGE) via several potential mechanisms, one of which is a Patent Foramen Ovale (PFO).
From: Dr. Schochet & Dr. Lie, Pediatric Pulmonologists
Reference OCHMO-TB-037 Decompression Sickness (DCS) Risk Mitigation technical brief for additional information.
A PFO is a shunt between the right atrium and the left atrium of the heart, which is a persisting remnant of a physiological communication present in the fetal heart. Post-natal increases in left atrial pressure usually force the inter-septal valve against the septum secundum and within the first 2 years of life, the septae permanently fuse due to the development of fibrous adhesions. Thus, all humans are born with a PFO and approximately 75% of PFOs fuse following childbirth. For the 25% of the population’s whose PFOs do not fuse, ~6% have what is considered by some to be a large PFO (> 2 mm). PFO diameter can increase with age. The concern with PFOs is that with a right to left shunt between the atria, venous emboli gas may pass from the right atrium (venous) to the left atrium (arterial) (“shunt”), thus by-passing the normal lung filtration of venous emboli which prevent passage to the arterial system. Without filtration, bubbles in the arterial system may lead to a neurological event such as a stroke. Any activity that increases the right atrium/venous pressure over the left atrium/arterial pressure (such as a Valsalva maneuver, abdominal compression) may further enable blood and/or emboli across a PFO/shunt.
From: Nuffield Department of Clinical Neurosciences
The purpose of this working group was to review and provide analysis on the status and progress of research and clinical activities intended to mitigate the risk of PFO and DCS issues during spaceflight. Identified cases of DCS during NASA exploration atmosphere ground testing conducted in pressurized chambers led to the prioritization of the given topic for external review. The main goals of the working group included:
Quantification of any increased risk associated with the presence of a PFO during decompression protocols utilized in ground testing and spaceflight EVAs, as well as unplanned decompressions (e.g., cabin depressurization, EVA suit leak). Describe risks and benefits of PFO screening in astronaut candidates, current crewmembers, and chamber test subjects. What are potential risk reduction measures that could be considered if a person was believed to be at increased risk of DCS due to a PFO? What research and/or technology development is recommended that could help inform and/or mitigate PFO-related DCS risk? The working group took place over two days at NASA’s Johnson Space Center and included NASA subject matter experts and stakeholders, as well as invited external reviewers from areas including cardiology, hypobaric medicine, spaceflight medicine, and military occupational health. During the working group, participants were asked to review past reports and evidence related to PFOs and risk of DCS, materials and information regarding NASA’s current experience and practices, and case studies and subsequent decision-making processes. The working group culminated in an open-forum discussion where recommendations for current and future practices were conferred and subsequently summarized in a final summary report, available on the public NASA OCHMO Standards Team website.
The following key findings are the main take-aways from the OCHMO independent assessment:
In an extreme exposure/high-risk scenario, excluding individuals with a PFO and treating PFOs does not necessarily decrease the risk of DCS or create a ‘safe’ environment. It may create incremental differences and slightly reduce overall risk but does not make the risk zero. There are other physiological factors that also contribute to the risk of DCS that may have a larger impact (see 7.0 Other Physiological Factors in the findings section). Based on the available evidence and the risk of current decompression exposures (based on current NASA protocols and NASA-STD-3001 requirements to limit the risk of DCS), it is not recommended to screen for PFOs in any spaceflight or ground testing participants. The best strategy to reduce the risk of DCS is to create as safe an environment as possible in every scenario, through effective prebreathe protocols, safety, and the capability to rapidly treat DCS should symptoms occur. Based on opinion, no specific research is required at this time to further characterize PFOs with DCS and altitude exposure, due to the low risk and preference to institute adequate safe protocols and ensuring treatment availability both on the ground and in spaceflight. For engineering protocols conducted on the ground, it should be ensured that the same level of treatment capability (treatment chamber in the immediate vicinity of the testing) is provided as during research protocols. The ability to immediately treat a DCS case is critical in ensuring the safety of the test subjects. The full summary report includes detailed background information, discussion points from the working group, and conclusions and recommendations. The findings from the working group and resulting summary report will help to inform key stakeholders in decision-making processes for future ground testing and spaceflight operations with the main goal of protecting crew health and safety to ensure overall mission success.
Summary Report About the Author
Sarah D. Childress
Share
Details
Last Updated Dec 31, 2024 Related Terms
Office of the Chief Health and Medical Officer (OCHMO) Human Health and Performance Humans in Space International Space Station (ISS) Explore More
2 min read Station Science Top News: Dec. 20, 2024
Article 2 weeks ago 4 min read Artemis II Core Stage Vertical Integration Begins at NASA Kennedy
Article 2 weeks ago 3 min read NASA, Axiom Space Change Assembly Order of Commercial Space Station
Article 2 weeks ago Keep Exploring Discover More Topics From NASA
Missions
Humans in Space
Climate Change
Solar System
View the full article
-
By NASA
Through NASA’s Artemis campaign, astronauts will land on the lunar surface and use a new generation of spacesuits and rovers as they live, work, and conduct science in the Moon’s South Pole region, exploring more of the lunar surface than ever before. Recently, the agency completed the first round of testing on three commercially owned and developed LTVs (Lunar Terrain Vehicle) from Intuitive Machines, Lunar Outpost, and Venturi Astrolab at NASA’s Johnson Space Center in Houston.NASA/Bill Stafford Venturi Astrolab’s FLEX, Intuitive Machines’ Moon RACER, and Lunar Outpost’s Eagle lunar terrain vehicle – three commercially owned and developed LTVs (Lunar Terrain Vehicle) – are pictured at NASA’s Johnson Space Center in Houston in this photo from Nov. 21, 2024.
As part of an ongoing year-long feasibility study, each company delivered a static mockup of their vehicle to Johnson at the end of September, initiated rover testing in October and completed the first round of testing in December inside the Active Response Gravity Offload System (ARGOS) test facility. Lunar surface gravity is one-sixth of what we experience here on Earth, so to mimic this, ARGOS offers an analog environment that can offload pressurized suited subjects for various reduced gravity simulations.
See how these LTVs were tested.
Image credit: NASA/Bill Stafford
View the full article
-
By NASA
3 min read
Preparations for Next Moonwalk Simulations Underway (and Underwater)
NASA’s Stennis Space Center near Bay St. Louis, Mississippi, is helping the Artemis Generation learn how to power space dreams with an interactive exhibit at INFINITY Science Center.
The engine test simulator exhibit at the official visitor center of NASA Stennis provides the chance to experience the thrill of being a NASA test engineer by guiding an RS-25 engine through a simulated hot fire test.
“It is an exhilarating opportunity to feel what it is like to be a NASA engineer, responsible for making sure the engine is safely tested for launch,” said Chris Barnett-Woods, a NASA engineer that helped develop the software for the exhibit.
Sitting at a console mirroring the actual NASA Stennis Test Control Center, users are immersed in the complex process of engine testing. The exhibit uses cutting-edge software and visual displays to teach participants how to manage liquid oxygen and liquid hydrogen propellants, and other essential elements during a hot fire.
A pair of young visitors to INFINITY Science Center carry out the steps of a simulated RS-25 engine hot fire on Dec. 19. The updated engine test simulator exhibit provided by NASA’s Stennis Space Center takes users through the hot fire process just as real engineers do at NASA Stennis.NASA/Danny Nowlin INFINITY Science Center, the official visitor center for NASA’s Stennis Space Center, has unveiled a new interactive simulator exhibit that allows visitors to become the test conductor for an RS-25 engine hot fire. NASA/Danny Nowlin Users follow step-by-step instructions that include pressing buttons, managing propellant tanks, and even closing the flare stack, just as real engineers do at NASA Stennis. Once the test is complete, they are congratulated for successfully conducting their own rocket engine hot fire.
The interactive exhibit is not just about pushing buttons. It is packed with interesting facts about the RS-25 engine, which helps power NASA’s Artemis missions as the agency explores secrets of the universe for the benefit of all. Visitors also can view real hot fires conducted at NASA Stennis from multiple angles, deepening their understanding of rocket propulsion testing and NASA’s journey back to the Moon and beyond.
NASA is currently preparing for the Artemis II mission, the first crewed flight test of the agency’s powerful SLS (Space Launch System) rocket and the Orion spacecraft around the Moon.
The first four Artemis missions are using modified space shuttle main engines tested at NASA Stennis. The center also achieved a testing milestone last April for engines to power future Artemis missions. For each Artemis mission, four RS-25 engines, along with a pair of solid rocket boosters, power NASA’s SLS rocket, producing more than 8.8 million pounds of total combined thrust at liftoff.
The revitalized exhibit, previously used when the visitor center was located onsite, represents a collaborative effort. It started as an intern project in the summer of 2023 before evolving into a full-scale experience. Engineers built on the initial concept, integrating carpentry, audio, and video to create the seamless experience to educate and inspire.
The best part might be that visitors to INFINITY Science Center can repeat the simulation as many times as they like, gaining confidence and learning more with each attempt.
“This exhibit was a favorite in the past, and with its new upgrades, the engine test simulator is poised to capture the imaginations of the Artemis Generation at INFINITY Science Center,” said NASA Public Affairs Specialist Samone Wilson. “This is one exhibit you will not want to miss.” INFINITY Science Center is located at 1 Discovery Circle, Pearlington, Mississippi. For hours of operation and admission information, please visit www.visitinfinity.com.
Share
Details
Last Updated Dec 20, 2024 EditorNASA Stennis CommunicationsContactC. Lacy Thompsoncalvin.l.thompson@nasa.gov / (228) 688-3333LocationStennis Space Center Related Terms
Stennis Space Center View the full article
-
-
Check out these Videos
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.